Acute Promyelocytic Leukemia with Fibrinogen and Factor V Deficiencies

Author:

DIDISHEIM PAUL11,TROMBOLD JOHN S.12,VANDERVOORT ROBERT L. E.13,MIBASHAN R. SOUGIN14

Affiliation:

1. Department of Medicine, University of Utah College of Medicine, Salt Lake City, Utah.

2. Department of Medicine, University of Utah College of Medicine, Salt Lake City, Utah. Present address: La Jolla, Calif.

3. Department of Medicine, University of Utah College of Medicine, Salt Lake City, Utah. Present address: Department of Medicine, University of Louvain, Louvain, Belgium

4. Department of Medicine, University of Utah College of Medicine, Salt Lake City, Utah. Present address: Departmnent of Medicine, University of Cape Town, Cape Town, South Africa

Abstract

Abstract 1. Two patients with acute promyelocytic leukemia (APL) are reported. Many of the promyelocytes were atypical. Of the 57 patients with this disorder in the literature, only three survived more than 4 months. Our patients underwent complete remission on 6-mercaptopurine, and survived 8 and 14 months, respectively. 2. Coagulation abnormalities in these two patients were thrombocytopenia; fibrinogen and factor V deficiencies; and, in one, prothrombin deficiency. These defects disappeared with remission, then reappeared terminally. In contrast to most previous reports, no increased fibrinolytic activity was found in their blood. Infused fibrinogen disappeared abnormally rapidly from the blood of one patient; this was not affected by simultaneous heparin administration, and no thrombi were seen at autopsy. 3. Fibrinogen, factor V, and prothrombin were assayed in 86 patients with other forms of leukemia before treatment or in relapse. Fibrinogen deficiency was found in none; prothrombin and/or factor V deficiency in eight. Three of these had acute myeloblastic, three acute myelomonoblastic, and two chronic myelocytic leukemia. 4. The characteristic cellular morphology, combined with the usual finding of fibrinogen and factor V deficiencies, makes for a distinct differentiation of APL from other forms of leukemia.

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3